CellMed
PrivateLast Round
Grant
Aug 25, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CellMed operates in Healthcare & Life Sciences and is based in South Korea. It was founded in 2008.
CellMed is a South Korean pharmaceutical and biotechnology company that develops anticancer drugs and functional nutraceutical products based on natural phytochemicals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, D2C Brands, Medical AI, Fashion & Beauty
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellMed Comparables
Compare CellMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yuhan Corporation | 69% | |
| Algocare | 63% | |
| Kick the Hurdle | 63% |
For institutional investors. Book with your work email.
CellMed Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
CellMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
$1.31M grant from the Government of South Korea
For institutional investors. Book with your work email.
CellMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellMed's valuation, stock price, and market status.
Is CellMed a public or private company?
CellMed is a private company.
What is the current stock price of CellMed?
CellMed is a private company, so its shares have no public market price. Caplight tracks CellMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellMed worth (valuation)?
Valuation information for CellMed is not publicly available.
Can I buy CellMed stock?
CellMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellMed's last funding round?
CellMed's most recent funding round was Grant on August 25, 2026.
Who are the main investors in CellMed?
Key investors in CellMed include Government of South Korea.
Will CellMed IPO soon?
No public IPO plans have been announced for CellMed.
How can I track CellMed secondary market activity?
Caplight tracks bids, offers, and trades in CellMed's shares on secondary markets.